Table: Phoenixbio -Q1 group results

PhoenixBio

12/08/2020 07:30

Aug 12 (Reuters)- 
             Phoenixbio Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended        Year to  
                Jun 30, 2020        Jun 30, 2019      Mar 31, 2021  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            162 mln             288 mln            1.35      
                 (-43.8 pct)         (+81.8 pct)       (+2.7 pct)   
  Operating     loss 133 mln         loss 81 mln       loss 50 mln  
  Recurring     loss 121 mln         loss 78 mln       loss 37 mln  
  Net           loss 121 mln         loss 78 mln       loss 39 mln  
  EPS          loss 39.64 yen      loss 26.90 yen    loss 12.23 yen 
  Ann Div                                NIL               NIL      
  -Q2 div                                NIL               NIL      
  -Q4 div                                NIL               NIL      
  
  NOTE - Phoenixbio Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=6190.T